mRNA-1283 COVID-19 variant-containing formulations

mRNA-1283 vaccine formulation · ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-1283 COVID-19 variant-containing formulations, covering 2025-10-14 to 2025-10-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations [Phase 4]

See pricing